Medication matters dominated the Aug. 18 meeting of the Kentucky Horse Racing Commission, which voted to change the descriptions for the drug classification schedules that are used to determine if a violation has occurred.
The Association of Racing Commissioners International's board of directors has unanimously approved a drug reclassification of stanozolol, boldenone, nandrolone, and testosterone, moving the anabolic steroids to Class 3 from Class 4.
A 45-day public comment period started March 2 on a series of rule amendments and additions under consideration by the California Horse Racing Board revising classification of drug substances and penalties for medication violations.
The California Horse Racing Board Medication Committee will consider major changes to the state's medication rules and penalties during a meeting Jan. 9 at Santa Anita Park.
Most Popular Stories
- Accelerate Springs Stunning Upset as Arrogate Falters
- Baffert Still Aiming Arrogate for Pacific Classic
- Stronach Group Explores Expansion into Massachusetts
- Focused Hemsworth Entered in Curlin Stakes
- Gutsy Move Gets Abel Tasman CCA Oaks Win
- Big World to be Offered at Fasig-Tipton November Sale
- Lady Eli Runs 'One of Her Greatest Races to Date'
- Abel Tasman, Elate Exit CCA Oaks in Good Order
- Hard Aces Looks for Repeat in Cougar II
- Awesome Banner Posts Bullet Ahead of Vanderbilt